February 5, 2001
AmeriPath Presents at the 2001 U.B.S. Warburg Global Healthcare Services Conference
FOR IMMEDIATE RELEASE
Michelle D. Getty
Investor Relations
AmeriPath, Inc.
561-845-1850
E-mail: invrel@ameripath.com
Riviera Beach, FL, February 5, 2001 - AmeriPath Inc,
(NASDAQ: PATH), the nation's largest company focused
on providing anatomic pathology, cancer diagnostic and
related healthcare information services, announced today
that Chairman and CEO, James C. New, will participate
in the 2001 UBS Warburg Global Healthcare Services Conference
at the Plaza Hotel in New York City on February 6, 2001. Mr.
New is scheduled to deliver the Company's presentation
at 11:00 a.m. EDT.
A listen-only telephone conference of the presentation
will be accessible to the public by calling 719-457-2605
and 888-515-2781 for the live dial-in, and 402-220-0705
and 877-803-5524 for the recorded line.
AmeriPath, Inc. is the nation's largest company focused
on providing anatomic pathology, cancer diagnostic and
related healthcare information services to physicians,
hospitals, national clinical laboratories and managed
care organizations. The Company's 426 physicians
provide medical services through 42 outpatient pathology
laboratories, 224 hospital inpatient laboratories, and
64 outpatient surgery centers in 21 states.
......................................................................................................................
The statements contained in this
press release may include "forward-looking
statements" which are based on management's current beliefs
and expectations. Past performance is not necessarily
indicative of future results. In addition, forward-looking
statements - which are identified by words such as "may", "should", "believe", "expect", "anticipate", "estimate" and
similar expressions - as well as any financial and operating
estimates, forecasts and/or projections, are subject
to a number of risks and uncertainties, many of which
involve factors or circumstances which are beyond the
Company's ability to control. These factors, risks
and uncertainties could cause actual results to differ
materially from historical results or those expected,
estimated or anticipated. These include factors,
risks and uncertainties relating to demand for pathology
and related services, pricing, federal and state regulation
(and compliance), reimbursement rates, government and
third party payments, dependence upon pathologists, key
personnel and contracts, completion and integration of
acquisitions and affiliations, competitive factors and
technology. The forward looking statements included
in this press release are made as of the date hereof,
and the Company undertakes no obligation to update or
revise any such statements, whether as result of new
developments, new information or otherwise. Further
information regarding risks, uncertainties and other
factors that could affect the Company's financial or
operating results, or which could cause actual results
to differ materially from those expected or anticipated,
are included in the Company's Form 10-K for the year
ended December 31, 1999 and subsequent filings with the
SEC.
